Artículos del autor

solaci

Femoropopliteal

2 Year Outcomes of Lutonix Drug Coated Balloon in Superficial Femoral Arteries

  There are plenty of clinical studies assessing the use of angioplasty for en la peripheral artery disease with restenosis rates...
solaci -
Coronary disease

Are Bioresorbable-Polymer Stents More Thrombogenic than Durable-Polymer Second-Generation Stents?

Courtesy of Dr. Cristian Jesús Rodríguez. Most stents currently used in percutaneous coronary intervention (PCI) are durable-polymer second-generation...
solaci -
Structural heart disease

Bleeding and Mortality in Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) is much less invasive than surgical replacement. This is associated with a substantial...
solaci -
Chronic Ischemic cardiopathy

Risk of Thrombosis and Bleeding with Peripheral Artery Disease and Concomitants

Peripheral artery disease (PAD) is no longer a systemic manifestation of atherosclerosis. In fact, 2 in 3...
solaci -
Fellowship

See All ProEducar “José Gabay” Course (Eighth Edition) Presentations

We are deeply thankful to all interventional physicians who, motivated by their great scientific and educational vocation,...
solaci -
Femoral

Common Femoral PCI Becomes a Valid Alternative

Gentileza del Dr. Carlos Fava. The common femoral artery has always been treated with surgery. Thanks to the...
solaci -
Congress News

President Dr. José Luis Leiva Pons Has Taken Office

SOLACI has a new president! Dr. José Luis Leiva Pons (Mexico) has taken over the reins of...
solaci -
Structural heart disease

How to standardize frailty in aortic stenosis patients

Frailty is the patient’s diminished capacity to recover after pathological or iatrogenic processes. It has a fundamental...
solaci -